Despite this progress, Dr. Greg Hillebrand, a senior skin scientist at Amway, a major health and beauty corporation, believes there is still a serious need for new methods and treatments for aging skin. “The pace of innovation in the anti-aging category is slowing. Conventional topical products like moisturizers, serums, and essences contain active ingredients aimed at preventing or reversing the signs of aging. Retinoids [a class of active ingredients] remain the gold standard, yet they have been around since the 1980s. The skin microbiota represents an exciting new focus area for us, and it’s the next best opportunity to solve many of the challenges associated with aging skin.” Dr. Hillebrand’s enthusiasm for the use of microbes goes back to 1995. He was sent to Japan by his former employer, Procter and Gamble, to figure out exactly how it worked by studying a prestige skincare line that consisted of a concentrated fungi ferment cultivated, processed, and filtered down into an essence product. “Many of my colleagues at the time did not actually believe it did anything; they all thought it was ‘foo-foo dust.’ I was only there for a few months when my director from the US came over to see how I was doing. I was excited to share my progress and ideas and met with him and my VP. I told them that I thought it might be possible that the fermented filtrate worked in part by favourably modulating the bacteria on the face in a way that we didn’t yet understand. Basically, I was proposing that the use of the product might shift the bacterial composition, perhaps maintaining the good ones and not the bad ones on the face.” In 1995, we didn’t yet appreciate the concept of “good” and “bad” bacteria on the skin—it simply wasn’t conceivable that the skin microflora were important; we certainly didn’t culture bacteria specifically to benefit the skin—so it was not surprising that the reaction of Dr. Hillebrand’s director to this novel idea was less than enthusiastic.
Thankfully, Dr. Hillebrand followed his hunch. Flash forward to present day, when he is critically involved in clinical studies and product testing for Amway explicitly focused on the microbes. Much of his team’s effort involves data gathering to better understand this emerging area. Amway set up a clinical test site, for example, during a major art event in Grand Rapids, Michigan, where they figured there would be a large variety of patrons of all ages in attendance. The Amway team measured the skin microbiome of hundreds of festival-goers via swabs of their scalps, foreheads, forearms, and nasal/oral areas. The samples showed fa